Avidity Biosciences Inc Sustainability Reports
Avidity Biosciences, Inc. is a biopharmaceutical company focused on the development of oligonucleotide-based therapies. It utilizes its proprietary antibody-oligonucleotide conjugates platform to target genetic drivers of diseases in rare neuromuscular conditions.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00FQ7LXX0
3 reports from 2020 to 2023
Company Profile
Avidity Biosciences, Inc. is a biopharmaceutical company focused on the development of oligonucleotide-based therapies. It utilizes its proprietary antibody-oligonucleotide conjugates platform to target genetic drivers of diseases in rare neuromuscular conditions.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
